Cattle lack vascular receptors for Escherichia coli O157:H7 Shiga toxins.

Escherichia coli O157:H7 causes Shiga toxin (Stx)-mediated vascular damage, resulting in hemorrhagic colitis and the hemolytic uremic syndrome in humans. These infections are often foodborne, and healthy carrier cattle are a major reservoir of E. coli O157:H7. We were interested in knowing why cattle are tolerant to infection with E. coli O157:H7. Cattle tissues were examined for the Stx receptor globotriaosylceramide (Gb(3)), for receptivity to Stx binding in vitro, and for susceptibility to the enterotoxic effects of Stx in vivo. TLC was used to detect Gb(3) in tissues from a newborn calf. Gb(3) was detected by TLC in kidney and brain, but not in the gastrointestinal tract. Immunohistochemistry was used to define binding of Stx1 and Stx2 overlaid onto sections from cattle tissues. Stx1 and Stx2 bound to selected tubules in the cortex of the kidney of both newborn calves (n = 3) and adult cattle (n = 3). Stx did not bind to blood vessels in any of the six gastrointestinal and five extraintestinal organs examined. The lack of Gb(3) and of Stx receptivity in the gastrointestinal tract raised questions about the toxicity of Stx in bovine intestine. We found that neither viable E. coli O157:H7 nor Stx-containing bacterial extracts were enterotoxic (caused fluid accumulation) in ligated ileal loops in newborn calves. The lack of vascular receptors for Stx provides insight into why cattle are tolerant reservoir hosts for E. coli O157:H7.

[1]  C. Lingwood.  Role of verotoxin receptors in pathogenesis. , 1996, Trends in microbiology.

[2]  Cathy A. Brown,et al.  Experimental Escherichia coli O157:H7 carriage in calves , 1997, Applied and environmental microbiology.

[3]  C. Lingwood,et al.  Verotoxin receptor glycolipid in human renal tissue. , 1989, Nephron.

[4]  R. Tauxe,et al.  The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. , 1991, Epidemiologic reviews.

[5]  R. Pebody,et al.  An international outbreak of Vero cytotoxin-producing Escherichia coli O157 infection amongst tourists; a challenge for the European infectious disease surveillance network , 1999, Epidemiology and Infection.

[6]  J. Samuel,et al.  Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents. , 1999, The Journal of infectious diseases.

[7]  S. Tzipori,et al.  Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets , 1987, Infection and immunity.

[8]  J. Morgan,et al.  Dysentery Caused by Escherichia coli (S102-9) in Calves: Natural and Experimental Disease , 1985, Veterinary pathology.

[9]  W. Cray,et al.  Experimental infection of calves and adult cattle with Escherichia coli O157:H7 , 1995, Applied and environmental microbiology.

[10]  J. Samuel,et al.  Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants , 1990, Infection and immunity.

[11]  L. Becker,et al.  The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. , 1988, Human pathology.

[12]  A. O’Brien,et al.  Isolation and characterization of monoclonal antibodies to Shiga-like toxin II of enterohemorrhagic Escherichia coli and use of the monoclonal antibodies in a colony enzyme-linked immunosorbent assay , 1988, Journal of clinical microbiology.

[13]  L. Gansheroff,et al.  Escherichia coli O157:H7 in beef cattle presented for slaughter in the U.S.: higher prevalence rates than previously estimated. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Ta,et al.  Postweaning diarrhea in swine: experimental model of enterotoxigenic Escherichia coli infection. , 1988 .

[15]  C. Pai,et al.  Experimental infection of infant rabbits with verotoxin-producing Escherichia coli , 1986, Infection and immunity.

[16]  Correlation of enterohemorrhagic Escherichia coli O157 prevalence in feces, hides, and carcasses of beef cattle during processing. , 2000 .

[17]  R. Moxley,et al.  Natural and experimental infection with an attaching and effacing strain of Escherichia coli in calves , 1986, Infection and immunity.

[18]  M. McKee,et al.  Profile of Escherichia coli O157:H7 pathogen responsible for hamburger-borne outbreak of hemorrhagic colitis and hemolytic uremic syndrome in Washington , 1993, Journal of clinical microbiology.

[19]  C. Lingwood.  Verotoxin-binding in human renal sections. , 1994, Nephron.

[20]  L. Beutin,et al.  Prevalence and some properties of verotoxin (Shiga-like toxin)-producing Escherichia coli in seven different species of healthy domestic animals , 1993, Journal of clinical microbiology.

[21]  H. Collins,et al.  Morphologic evaluation of the effects of Shiga toxin and E coli Shiga-like toxin on the rabbit intestine. , 1986, The American journal of pathology.

[22]  J. Samuel,et al.  Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages , 1994, Infection and immunity.

[23]  V. Jay,et al.  Experimental verocytotoxemia in rabbits , 1992, Infection and immunity.

[24]  A. Melton,et al.  Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model , 1993, Infection and immunity.

[25]  H. Smith,et al.  Observations by the ligated intestinal segment and oral inoculation methods on Escherichia coli infections in pigs, calves, lambs and rabbits. , 1967, The Journal of pathology and bacteriology.

[26]  R. Holmes,et al.  Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli , 1985, Infection and immunity.

[27]  G. Remuzzi,et al.  Verotoxin glycolipid receptors determine the localization of microangiopathic process in rabbits given verotoxin-1. , 1992, The Journal of laboratory and clinical medicine.

[28]  C. Gyles,et al.  Localization of potential binding sites for the edema disease verotoxin (VT2e) in pigs. , 1998, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

[29]  M. Donowitz,et al.  Pathogenesis of Shigella diarrhea. XVI. Selective targetting of Shiga toxin to villus cells of rabbit jejunum explains the effect of the toxin on intestinal electrolyte transport. , 1989, The Journal of clinical investigation.

[30]  R. Clarke,et al.  Colitis in calves: natural and experimental infection with a verotoxin-producing strain of Escherichia coli O111:NM. , 1988, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

[31]  J Kelly,et al.  The Colonic Pathology of Escherichia coli 0157: H7 Infection , 1990, The American journal of surgical pathology.

[32]  J. Dalrymple,et al.  Quantitative microtiter cytotoxicity assay for Shigella toxin , 1980, Journal of clinical microbiology.

[33]  W. Cray,et al.  Pathogenicity of Escherichia coli O157:H7 in the intestines of neonatal calves , 1997, Infection and immunity.

[34]  G. Tyrrell,et al.  Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs , 1993, The Journal of experimental medicine.